Quantitative Proteomics Reveals Cellular Targets of Celastrol

Celastrol, a natural substance isolated from plant extracts used in traditional Chinese medicine, has been extensively investigated as a possible drug for treatment of cancer, autoimmune diseases, and protein misfolding disorders. Although studies focusing on celastrol's effects in specific cellular pathways have revealed a considerable number of targets in a diverse array of in vitro models there is an essential need for investigations that can provide a global view of its effects. To assess cellular effects of celastrol and to identify target proteins as biomarkers for monitoring treatment regimes, we performed large-scale quantitative proteomics in cultured human lymphoblastoid cells, a cell type that can be readily prepared from human blood samples. Celastrol substantially modified the proteome composition and 158 of the close to 1800 proteins with robust quantitation showed at least a 1.5 fold change in protein levels. Up-regulated proteins play key roles in cytoprotection with a prominent group involved in quality control and processing of proteins traversing the endoplasmic reticulum. Increased levels of proteins essential for the cellular protection against oxidative stress including heme oxygenase 1, several peroxiredoxins and thioredoxins as well as proteins involved in the control of iron homeostasis were also observed. Specific analysis of the mitochondrial proteome strongly indicated that the mitochondrial association of certain antioxidant defense and apoptosis-regulating proteins increased in cells exposed to celastrol. Analysis of selected mRNA transcripts showed that celastrol activated several different stress response pathways and dose response studies furthermore showed that continuous exposure to sub-micromolar concentrations of celastrol is associated with reduced cellular viability and proliferation. The extensive catalog of regulated proteins presented here identifies numerous cellular effects of celastrol and constitutes a valuable biomarker tool for the development and monitoration of disease treatment strategies.

[1]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[2]  N. Hay,et al.  Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt , 2006, Oncogene.

[3]  María Martín,et al.  The Universal Protein Resource (UniProt) in 2010 , 2010 .

[4]  W. Lu,et al.  Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L. , 2010, Cancer letters.

[5]  Baris E. Suzek,et al.  The Universal Protein Resource (UniProt) in 2010 , 2009, Nucleic Acids Res..

[6]  Young-Soo Hong,et al.  Inhibition of NF-κB activation through targeting IκB kinase by celastrol, a quinone methide triterpenoid , 2006 .

[7]  R. Kaufman,et al.  Adaptation to ER Stress Is Mediated by Differential Stabilities of Pro-Survival and Pro-Apoptotic mRNAs and Proteins , 2006, PLoS biology.

[8]  S. Carr,et al.  A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.

[9]  S. Westerheide,et al.  Triptolide, an Inhibitor of the Human Heat Shock Response That Enhances Stress-induced Cell Death* , 2006, Journal of Biological Chemistry.

[10]  M. Moore.  Characterization of the enzyme , 1994 .

[11]  C. Hetz,et al.  Modulating stress responses by the UPRosome: a matter of life and death. , 2011, Trends in biochemical sciences.

[12]  Jiandie D. Lin,et al.  Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1. , 2010, American journal of hypertension.

[13]  J. Reichheld,et al.  Thioredoxins and glutaredoxins: unifying elements in redox biology. , 2009, Annual review of genetics.

[14]  I. Raskin,et al.  Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. , 2010, Current drug discovery technologies.

[15]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[16]  U. Jakob,et al.  Redox-regulated chaperones. , 2009, Biochemistry.

[17]  P. Bross,et al.  Mitochondrial proteomics on human fibroblasts for identification of metabolic imbalance and cellular stress , 2008, Proteome Science.

[18]  A. Salminen,et al.  Celastrol: Molecular targets of Thunder God Vine. , 2010, Biochemical and biophysical research communications.

[19]  M. Mann,et al.  A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) , 2006, Nature Protocols.

[20]  M. Mongillo,et al.  Role of ERO1-α–mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress–induced apoptosis , 2009, The Journal of cell biology.

[21]  P. Bross,et al.  A cellular viability assay to monitor drug toxicity. , 2010, Methods in molecular biology.

[22]  B. Aggarwal,et al.  Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death Receptors* , 2010, The Journal of Biological Chemistry.

[23]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[24]  Jun O. Liu,et al.  XPB, a subunit of TFIIH, is a target of the natural product triptolide. , 2011, Nature chemical biology.

[25]  G. Sethi,et al.  Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. , 2011, Cancer letters.

[26]  A. Chow,et al.  Induction of heat shock proteins in differentiated human and rodent neurons by celastrol , 2007, Cell stress & chaperones.

[27]  Qiaojun He,et al.  Synergistic Anti-Cancer Activity by the Combination of TRAIL/APO-2L and Celastrol , 2010, Cancer investigation.

[28]  M. Karin,et al.  Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. , 2009 .

[29]  Young-Soo Hong,et al.  Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. , 2006, Biochemical pharmacology.

[30]  Cole M. Haynes,et al.  The mitochondrial UPR – protecting organelle protein homeostasis , 2010, Journal of Cell Science.

[31]  P. Lipsky,et al.  Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. , 2002, Arthritis and rheumatism.

[32]  Michael Karin,et al.  Is NF-κB a good target for cancer therapy? Hopes and pitfalls , 2009, Nature Reviews Drug Discovery.

[33]  S. Westerheide,et al.  Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. , 2007, Molecular biology of the cell.

[34]  Yi-Te Hsu,et al.  Movement of Bax from the Cytosol to Mitochondria during Apoptosis , 1997, The Journal of cell biology.

[35]  P. Lipsky,et al.  The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. , 2000, Rheumatic diseases clinics of North America.

[36]  P. Karplus,et al.  Typical 2‐Cys peroxiredoxins – structures, mechanisms and functions , 2009, The FEBS journal.

[37]  M. Beal,et al.  Celastrol Blocks Neuronal Cell Death and Extends Life in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis , 2006, Neurodegenerative Diseases.

[38]  H. Marver,et al.  Microsomal heme oxygenase. Characterization of the enzyme. , 1969, The Journal of biological chemistry.

[39]  S. Westerheide,et al.  Celastrols as Inducers of the Heat Shock Response and Cytoprotection*[boxs] , 2004, Journal of Biological Chemistry.

[40]  B. Aggarwal,et al.  Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. , 2007, Blood.

[41]  John Eric Wilson.  Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function , 2003, Journal of Experimental Biology.

[42]  A. Allison,et al.  Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  P. Srivastava,et al.  Heat‐Shock Proteins , 2003, Current protocols in immunology.

[44]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[45]  Jawed Alam,et al.  Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. , 2006, Physiological reviews.

[46]  Guang-Biao Zhou,et al.  The Main Anticancer Bullets of the Chinese Medicinal Herb, Thunder God Vine , 2011, Molecules.

[47]  Lin Fang,et al.  WEGO: a web tool for plotting GO annotations , 2006, Nucleic Acids Res..

[48]  John R. Yates,et al.  Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases , 2008, Cell.

[49]  G. Sethi,et al.  Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways , 2011, Apoptosis.

[50]  A. Durr,et al.  Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13) , 2008, Neuroscience.

[51]  M. Ryan,et al.  A mitochondrial specific stress response in mammalian cells , 2002, The EMBO journal.

[52]  S. Oyadomari,et al.  Roles of CHOP/GADD153 in endoplasmic reticulum stress , 2004, Cell Death and Differentiation.

[53]  V. Shoshan-Barmatz,et al.  Uncovering the role of VDAC in the regulation of cell life and death , 2008, Journal of bioenergetics and biomembranes.

[54]  Anders D. Børglum,et al.  Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter , 2002, Human Genetics.

[55]  H. Schwalbe,et al.  Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. , 2009, Angewandte Chemie.

[56]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[57]  P. Lipsky,et al.  Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). , 2007, Phytochemistry.

[58]  N. Bulleid,et al.  Peroxiredoxin IV protects cells from oxidative stress by removing H2O2 produced during disulphide formation , 2010, Journal of Cell Science.